Metabolic Inflammation in Obesity—At the Crossroads between Fatty Acid and Cholesterol Metabolism
- 5 August 2020
- journal article
- review article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 65 (1) , e1900482
Abstract
Metabolic inflammation is a classic hallmark of obesity that is associated with numerous cardiometabolic complications. Disturbances in fatty acid and cholesterol metabolism are evident in obesity and likely intricately linked to the development and/or sustainment of metabolic inflammation and insulin resistance. Elevations in triglyceride‐rich lipoproteins and reductions in high‐density lipoprotein‐cholesterol in turn are two major disturbances that accompany obesity. How metabolic dyslipidemia may contribute to metabolic inflammation is discussed. How aberrant cholesterol homeostasis coupled with excessive fatty acid accumulation prime pro‐IL‐1β and the evidence to support a synergistic partnership between cholesterol and fatty acids in driving metabolic inflammation are also discussed. Further, pharmaceutical and nutraceutical strategies aimed at attenuating low‐grade inflammation and implications for cardiometabolic complications of obesity are reviewed. The current literature on the importance of the local tissue microenvironment in activating adipose tissue macrophages within obese adipose tissue and the contribution of these local immune cells to metabolic inflammation is reviewed. Finally, the limitations to current biomarkers of metabolic inflammation and the importance of novel sensitive biomarkers in driving obesity sub‐type characterization to direct personalized medicine approaches to obesity treatment in the future are discussed.Keywords
Funding Information
- Science Foundation Ireland
This publication has 135 references indexed in Scilit:
- Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetesNature Genetics, 2012
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistanceNature Medicine, 2011
- Characterizing the profile of obese patients who are metabolically healthyInternational Journal of Obesity, 2010
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- Regulation of hepatic gene expression by saturated fatty acidsProstaglandins, Leukotrienes and Essential Fatty Acids, 2010
- Interferon γ Attenuates Insulin Signaling, Lipid Storage, and Differentiation in Human Adipocytes via Activation of the JAK/STAT PathwayJournal of Biological Chemistry, 2009
- Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpeneCancer Letters, 2009
- Ablation of CD11c-Positive Cells Normalizes Insulin Sensitivity in Obese Insulin Resistant AnimalsCell Metabolism, 2008
- Comparison of Usefulness of Body Mass Index Versus Metabolic Risk Factors in Predicting 10-Year Risk of Cardiovascular Events in WomenThe American Journal of Cardiology, 2007
- Inflammation and metabolic disordersNature, 2006